Rockwell Medical (RMTI) Non-Current Debt (2013 - 2026)
Rockwell Medical (RMTI) posted Non-Current Debt of $8.2 million for Q1 2026, down 7.01% on a QoQ basis from $8.8 million in Q4 2025, and down 4.11% year-over-year from $8.6 million in Q1 2025.
Rockwell Medical (RMTI) Non-Current Debt (2013 - 2026) Analysis & Trends
Rockwell Medical's Non-Current Debt history runs 10 years deep, the most recent figure standing at $8.2 million for Q1 2026.
- Quarterly Non-Current Debt fell 4.11% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (down 4.11% YoY) and the FY2025 annual result came in at $8.8 million, up 4.18% from the prior year.
- Non-Current Debt was $8.2 million for Q1 2026 at Rockwell Medical, down from $8.8 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $11.8 million in Q1 2022 and bottomed at $503000.0 in Q4 2022.
- A 5-year average of $7.5 million and a median of $8.4 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt sank 96.19% — and 2023, when it surged 1548.71%.
- Rockwell Medical's Non-Current Debt stood at $503000.0 in 2022, then surged by 1548.71% to $8.3 million in 2023, then climbed by 2.16% to $8.5 million in 2024, then rose by 4.18% to $8.8 million in 2025, then slipped by 7.01% to $8.2 million in 2026.
- Business Quant data shows RMTI's Non-Current Debt at $8.2 million in Q1 2026, $8.8 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 8.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.21 Mn |
| Dec 31, 2025 | 8.83 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 8.65 Mn |
| Mar 31, 2025 | 8.56 Mn |
| Dec 31, 2024 | 8.47 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.30 Mn |
| Mar 31, 2024 | 8.27 Mn |
| Dec 31, 2023 | 8.29 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 733,000.00 |
| Dec 31, 2022 | 503,000.00 |
| Sep 30, 2022 | 8.96 Mn |
| Jun 30, 2022 | 10.37 Mn |
| Mar 31, 2022 | 11.78 Mn |
| Dec 31, 2021 | 13.19 Mn |
| Sep 30, 2021 | 14.09 Mn |
| Mar 31, 2021 | 21.04 Mn |
| Dec 31, 2020 | 20.95 Mn |